These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38143377)

  • 1. Three or four doses of intravenous immunoglobulin G treatment for isoimmune hemolytic disease: A case series and literature review.
    Zheng Y; Almeyda-Alejo Y; Tumin D; Redpath NSJ; Guillen-Hernandez J
    J Neonatal Perinatal Med; 2024; 17(1):153-158. PubMed ID: 38143377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study.
    Al-Lawama M; Badran E; Elrimawi A; Bani Mustafa A; Alkhatib H
    J Clin Med Res; 2019 Nov; 11(11):760-763. PubMed ID: 31803318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.
    Okulu E; Erdeve O; Kilic I; Olukman O; Calkavur S; Buyukkale G; Cetinkaya M; Ulubas D; Demirel N; Hanta D; Ertugrul S; Gultekin ND; Tuncer O; Demir N; Bilgin L; Narli N; Yildiz D; Terek D; Koroglu OA; Seren C; Ozyazici E; Ozdemir R; Turgut H; Narter F; Akin Y; Ozyazici A; Zenciroglu A; Asker HS; Gokmen Z; Salihli M; Bulbul A; Zubarioglu U; Atasay B; Koc E;
    Front Pediatr; 2022; 10():864609. PubMed ID: 35573949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin for alloimmune hemolytic disease in neonates.
    Zwiers C; Scheffer-Rath ME; Lopriore E; de Haas M; Liley HG
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD003313. PubMed ID: 29551014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous immunoglobulin on the management of Rh- and ABO-mediated hemolytic disease of the newborn.
    Jalali SZ; Mahdipour S; Asgarzad R; Saadat F
    Hematol Transfus Cell Ther; 2024 Apr; ():. PubMed ID: 38719722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study.
    Pan J; Zhan C; Yuan T; Chen X; Ni Y; Shen Y; Chen W; Wu T; Yu H
    J Perinatol; 2021 Jun; 41(6):1397-1402. PubMed ID: 33589732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
    Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
    Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
    Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
    Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
    Alcock GS; Liley H
    Cochrane Database Syst Rev; 2002; (3):CD003313. PubMed ID: 12137687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia.
    Rasiah S; Jegathesan T; Campbell DM; Shah PS; Sgro MD
    Pediatr Res; 2023 Dec; 94(6):2092-2097. PubMed ID: 37491586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.
    Tanyer G; Siklar Z; Dallar Y; Yildirmak Y; Tiraş U
    J Trop Pediatr; 2001 Feb; 47(1):50-3. PubMed ID: 11245352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: a retrospective 11-year study.
    Lieberman L; Spradbrow J; Keir A; Dunn M; Lin Y; Callum J
    Transfusion; 2016 Nov; 56(11):2704-2711. PubMed ID: 27459953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.